Literature DB >> 27391092

Incidence, Risk Factors, and Surgical Management of Boston Type 1 Keratoprothesis Corneal Melts, Leaks, and Extrusions.

Clara C Chan1, Lorena LoVerde, Judy Qiang, Michael L Nordlund, Edward J Holland.   

Abstract

PURPOSE: To determine the rate of Boston type 1 keratoprosthesis (Kpro)-related corneal melts, leaks, and extrusions requiring surgical repair and to analyze possible risk factors and visual outcomes.
METHODS: Retrospective chart review of 110 patients (128 eyes) who received a Kpro between November 2004 and December 2010 (average follow-up of 29 mo). The rate of corneal complications, risk factors for melts, and postmelt repair visual outcomes were evaluated.
RESULTS: Twenty eyes from 18 patients developed Kpro-related melts requiring surgical repair. The incidence of melt-related complications was 16%. In total, there were 33 episodes of melt-related complications. Surgical repair included lamellar patch grafts (15), Kpro removal with penetrating keratoplasty (7), reassembly of Kpro onto a new cornea (4), replacement of Kpro (3), suturing of a leak (3), and enucleation (1). The majority of eyes (18/20) did not regain their best post-Kpro vision at final follow-up (average 10 mo and range, 1-36 mo after melt repair). Significant risk factors for melt included previous infectious keratitis [P < 0.0001, odds ratio (OR) = 12.50, 95% confidence interval (CI), 4.02-38.9] and conjunctival deficiency (ie, a diagnosis of Stevens-Johnson syndrome, mucous membrane pemphigoid, or chemical injury, P = 0.043, OR = 2.66, CI, 1.01-7.02).
CONCLUSIONS: Patients who undergo Kpro with severe ocular surface disease are at greater risk for corneal melts, leaks, and extrusions. Patients with infectious keratitis and conjunctival deficiency are at an increased risk of developing corneal melts. Visual outcomes are poor after surgical repair of these complications.

Entities:  

Mesh:

Year:  2016        PMID: 27391092     DOI: 10.1097/ICO.0000000000000911

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  5 in total

1.  Boston keratoprosthesis type 1: outcomes of the first 38 cases performed at Moorfields Eye Hospital.

Authors:  Chameen Samarawickrama; Nicholas Strouthidis; Mark R Wilkins
Journal:  Eye (Lond)       Date:  2018-02-14       Impact factor: 3.775

Review 2.  [Treatment of vascularized high-risk eyes with a Boston keratoprosthesis].

Authors:  F Schaub; M Matthaei; P Enders; S Siebelmann; D Hos; B O Bachmann; C Cursiefen
Journal:  Ophthalmologe       Date:  2021-03-17       Impact factor: 1.059

Review 3.  Keratoprosthesis: Current global scenario and a broad Indian perspective.

Authors:  Geetha Iyer; Bhaskar Srinivasan; Shweta Agarwal; Deepti Talele; Ekta Rishi; Pukhraj Rishi; Sripriya Krishnamurthy; Lingam Vijaya; Nirmala Subramanian; Shanmugasundaram Somasundaram
Journal:  Indian J Ophthalmol       Date:  2018-05       Impact factor: 1.848

Review 4.  Boston Type 1 Keratoprosthesis: Updated Perspectives.

Authors:  Manachai Nonpassopon; Muanploy Niparugs; Maria Soledad Cortina
Journal:  Clin Ophthalmol       Date:  2020-04-29

5.  Comments on: Keratoprosthesis optic and carrier corneal graft "noncontact" as a cause of sterile stromal necrosis in a case of Auro KPro implantation.

Authors:  Mona Harissi-Dagher; Yasmin Awad
Journal:  Indian J Ophthalmol       Date:  2020-01       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.